EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Prunus mume Extract Inhibits SARS-CoV-2 and Influenza Virus Infection In Vitro by Directly Targeting Viral Particles

Mizuki Tokusanai, Koichiro Tateishi, Kanako Hirata, Nahoko Fukunishi, Yusuke Suzuki, Ryohei Kono iD, Sorama Natsumi, Chikara Kato, Susumu Takekoshi, Yoshiharu Okuno iD, Hirotoshi Utsunomiya, Norio Yamamoto

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26178487 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Mizuki Tokusanai und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan. Hauptthemen laut MEDLINE: Plant Extracts, SARS-CoV-2, Antiviral Agents, Prunus. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 57 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Japan Society for the Promotion of Science, Tokai University, Minabecho.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza virus are major respiratory pathogens associated with substantial morbidity and a risk of severe disease. However, the effectiveness of current vaccines and antiviral drugs is limited by viral mutations. Umeboshi, a traditional Japanese food prepared from pickled Prunus mume, is known for its health benefits; certain components of P. mume have exhibited antimicrobial properties. However, the efficacy of P. mume against SARS-CoV-2 and influenza virus remains unknown. We aimed to examine the antiviral activity of P. mume extracts against SARS-CoV-2 and influenza virus. Cytopathic effect (CPE) assays and reverse transcription–quantitative polymerase chain reaction (RT-qPCR) analyses with full-time treatment demonstrated that four extracts (PM2, PM3, PM4, and PM6) among eight tested inhibited the replication of both viruses. Subsequent time-of-addition assays, plaque assays, and transmission electron microscopy (TEM) confirmed that PM2 directly inactivated viral particles of both viruses by disrupting their structural integrity. Additional evaluations of virion integrity and infectivity suggested that the antiviral activity of PM2 may also involve mechanisms other than direct virion disruption. These findings suggest that P. mume-derived components exhibit direct antiviral activities against SARS-CoV-2 and influenza virus, supporting their potential development as antiviral agents or infection-preventive dietary products.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Plant ExtractsSARS-CoV-2Antiviral AgentsPrunusVirionHumansVirus ReplicationAnimalsChlorocebus aethiopsDogsVero CellsMadin Darby Canine Kidney CellsCOVID-19 Drug TreatmentCOVID-19

Stichwörter der Autor:innen

Prunus mumeSARS-CoV-2Umeboshiantiviral activityinfluenza virusviral inactivationvirucidal mechanism

Substanzen

Plant ExtractsAntiviral Agents

Autor:innen und Institutionen

  • Department of Microbiology, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan.
  • Department of Emergency and Critical Care Medicine, Tokai University School of Medicine, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan.
  • Department of Life Science Support, Research Innovation Center, University Hospitals Sector, Tokai University, 143 Shimokasuya, Isehara 259-1193, Kanagawa, Japan.
  • Department of Rehabilitation, Osaka Kawasaki Rehabilitation University, 158 Mizuma, Kaizuka 597-0104, Osaka, Japan.
  • Department of Applied Chemistry and Biochemistry, National Institute of Technology, Wakayama College, 77 Noshima, Nada, Gobo 644-0023, Wakayama, Japan.

ORCID-Profile: Ryohei Kono, Yoshiharu Okuno

Förderung

  • Japan Society for the Promotion of Science
  • Tokai University
  • Minabecho
  • JSPS KAKENHI
  • Research and Study Project of Tokai University
  • Tokai University School of Medicine Project Research
  • Minabecho Collaborative Research Project
  • Research Promotion Grant from Tokai University

Zitieren

APA

Tokusanai, M., Tateishi, K., Hirata, K., Fukunishi, N., Suzuki, Y., Kono, R., Natsumi, S., Kato, C., Takekoshi, S., Okuno, Y., Utsunomiya, H., & Yamamoto, N. (2025). Prunus mume Extract Inhibits SARS-CoV-2 and Influenza Virus Infection In Vitro by Directly Targeting Viral Particles. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26178487

Vancouver

Tokusanai M, Tateishi K, Hirata K, Fukunishi N, Suzuki Y, Kono R, et al. Prunus mume Extract Inhibits SARS-CoV-2 and Influenza Virus Infection In Vitro by Directly Targeting Viral Particles. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26178487

BibTeX
@article{Tokusanai2025,
  author = {Tokusanai, Mizuki and Tateishi, Koichiro and Hirata, Kanako and Fukunishi, Nahoko and Suzuki, Yusuke and Kono, Ryohei and Natsumi, Sorama and Kato, Chikara and Takekoshi, Susumu and Okuno, Yoshiharu and Utsunomiya, Hirotoshi and Yamamoto, Norio},
  title = {Prunus mume Extract Inhibits SARS-CoV-2 and Influenza Virus Infection In Vitro by Directly Targeting Viral Particles},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26178487}
}
Kostenlos starten →